Recent Articles from Business Wire

LCI Industries (NYSE: LCII) today announced that the company and Patrick Industries (NASDAQ: PATK) have terminated discussions regarding a potential merger of equals, as the companies were unable to reach mutually agreeable terms. LCI Industries and Patrick Industries each previously confirmed discussions on April 17 and noted there could be no assurance that any such agreement would be reached.

Rejoni, Inc., a privately held clinical-stage company based in Bedford, MA, dedicated to elevating uterine health through innovative biomaterial therapies, today announced the appointment of John Nealon as Chief Executive Officer.

TWO (Two Harbors Investment Corp, NYSE: TWO), an MSR-focused REIT, today reaffirmed the unanimous support of the TWO Board of Directors for the Company’s previously announced amended transaction with CrossCountry Mortgage, LLC (“CrossCountry” or “CCM”).

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced the primary endpoint was met in the VISTAS Phase 2b study evaluating volixibat, an investigational oral ileal bile acid transporter (IBAT) inhibitor, in patients with primary sclerosing cholangitis (PSC).

TOMS Capital Investment Management (“TCIM”), one of the largest shareholders of Voya Financial, Inc. (NYSE: VOYA), today issued the following statement:

Assertio Holdings, Inc. (Nasdaq: ASRT) (“Assertio” or the “Company”) today announced that, on May 1, 2026, Assertio and Garda Therapeutics (“Garda”) entered into an Amended and Restated Agreement and Plan of Merger (the “Merger Agreement”), pursuant to which Garda has increased its offer to acquire all outstanding shares of Assertio to $21.80 per share in cash with no contingent value right.

The Depository Trust & Clearing Corporation (DTCC), the premier post-trade market infrastructure for the global financial services industry, today announced progress and timelines on the delivery of The Depository Trust Company’s (DTC’s) tokenization service, which is being designed with feedback and collaboration from more than 50 financial industry firms.

WEX (NYSE: WEX) (“WEX” or the “Company”), a global leader in intelligent payment solutions, today announced that it has entered into a cooperation agreement with Impactive Capital Master Fund LP (“Impactive”).

PHINIA INC. (NYSE: PHIN), a global leader in premium fuel systems, electrical systems and aftermarket solutions, today announced its participation in ACT Expo 2026, taking place May 4-7 at the Las Vegas Convention Center, NV, United States. Visitors can find PHINIA at booth #3274, where the company will highlight its latest innovations in lower-carbon transportation, including the debut of its first homologated hydrogen internal combustion engine (H2ICE) light commercial vehicle (LCV), certified for on-road use and marking a step forward in the development of hydrogen combustion engines.

Blend Labs, Inc. (NYSE: BLND), a leading digital origination platform for banks, credit unions, and mortgage lenders, today announced the launch of Autopilot MCP, a server built on Model Context Protocol, the emerging open standard for AI agent connectivity, that gives authorized agents secure, programmatic access to the full Blend platform.

NuCube Energy, Inc. (“NuCube”), a developer of high-temperature modular microreactors, today announced the establishment of its initial on-the-ground presence in Phoenix and the appointment of Michael Green as Chief Legal Officer. The expansion follows NuCube's recent award under the U.S. Department of Energy Gateway for Accelerated Innovation in Nuclear (GAIN) program, and builds on momentum from its selection by the Department of Energy for the Nuclear Energy Launch Pad (USA) program, a competitive fast-track initiative for advanced nuclear deployment, announced this week.

Easterly Government Properties, Inc. (NYSE: DEA), a fully integrated real estate investment trust focused primarily on the acquisition, development and management of Class A commercial properties leased to the U.S. Government and its adjacent partners, announced today that management will participate in investor meetings at Wells Fargo’s 29th Annual Real Estate Securities Conference in Charleston, South Carolina on May 4, 2026.

IonQ (NYSE: IONQ), the world’s leading quantum technology company, today announced the commercial launch of Interferometric Synthetic Aperture Radar (InSAR) capabilities through its space missions line. The offering enables millimeter-precision ground deformation monitoring with fully automated tasking and data delivery – enabling customers to detect and track physical change on the Earth’s surface consistently, at a frequency and scale never previously available from a commercial SAR provider.

DXP Enterprises, Inc. (the “Company”) (NASDAQ: DXPE), a leading business to business products and service distributor that adds value and total cost savings solutions to MRO and OEM customers in virtually every industry, plans to issue a press release announcing its financial results for the first quarter ended March 31, 2026, on Thursday, May 7th. The earnings announcement will be released before the market opens. DXP will host a conference call, to be webcast live, on the Company’s website (www.dxpe.com) at 3:30 PM Central Time on Thursday, May 7th.

The Baltimore-Washington region has seen meaningful improvements in air quality over the past decade, but maintaining clean air requires ongoing effort from everyone. This Air Quality Awareness Week (May 4–10, 2026), Clean Air Partners is encouraging residents to take a closer look at their lawn care routines and the hidden pollution costs that come with them.

Hess Midstream LP (NYSE: HESM) (“Hess Midstream” or the “Company”) today reported first quarter 2026 net income of $157.7 million compared with net income of $161.4 million for the first quarter of 2025. After deduction for noncontrolling interests, net income attributable to Hess Midstream was $87.6 million, or $0.68 basic earnings per Class A share, compared with $0.65 basic earnings per Class A share in the first quarter of 2025. Hess Midstream generated Adjusted EBITDA of $299.8 million. Net cash provided by operating activities was $253.3 million and Adjusted Free Cash Flow was $237.0 million.

Nearly half (47%) of U.S. residents oppose the construction of an artificial intelligence data center in their neighborhood, while 38% support it. This is according to a survey fielded by Ipsos and commissioned by Redfin, the real estate brokerage powered by Rocket.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing “off the shelf” allogeneic cell therapies for serious medical conditions, today announced that 36-month results from patients enrolled in a Phase 1/2a clinical study (ClinicalTrials.gov Identifier: NCT02286089) of RG6501 (OpRegen) in patients with geographic atrophy (GA) secondary to age-related macular degeneration (AMD), were presented at the Foundation Fighting Blindness’ Retinal Therapeutics Innovation Summit 2026. The presentation, “Retinal Pigment Epithelium (RPE) Cell Therapy in Geographic Atrophy Secondary to Age-related Macular Degeneration: 3 Year Results from the Phase 1/2a Study,” was presented by Eyal Banin, M.D., Ph.D., Center for Retinal and Macular Degenerations, Department of Ophthalmology Hadassah-Hebrew University Medical Center and Faculty of Medicine, on behalf of Roche and Genentech, a member of the Roche Group.

Proof, an identity authorization network that has secured over $640 billion in transactions for more than 9,000 organizations, today announced it has joined the FIDO Alliance, the industry group behind authentication standards like passkeys and WebAuthn, as those standards expand to support AI agents acting on behalf of users. Proof joins as a Sponsor member at a moment when FIDO has made agent-based interactions a central priority for 2026.

Higher education marketing and research firm Validated Insights today released not just a new report on the future of the online program management (OPM) market, but an entirely new kind of report in market and education analytics – a MiroFish, the AI swarm intelligence system designed to simulate complex social dynamics and predict future events, according to public descriptions.

MarineMax, Inc. (NYSE: HZO) today announced that SkipperBud’s, a MarineMax company, has been named the operator of North Point Marina in Winthrop Harbor, Illinois, the largest marina on the Great Lakes.

True Anomaly today announced its expansion into space-based interceptors (“SBIs”) and its selection to perform within the U.S. Space Force Space Systems Command (“SSC”) SBI program. As part of Golden Dome for America, the SBI program responds to a generational mandate to protect the United States homeland from potential ballistic missile and hypersonic attacks.

Toast (NYSE: TOST), the global technology platform built for hospitality, today announced its affiliation with Preferred Hotels & Resorts as the latest addition to the brand’s Alliance Partner Program. This partnership solidifies Toast’s position as a recommended provider of point-of-sale (POS) technology, including software, hardware, and payments, for Preferred Hotels & Resorts member properties across the United States, United Kingdom, Ireland, and Canada, providing the technology foundation needed to power complex, multi-concept hotel food, beverage and retail environments.

JLens, a Registered Investment Advisor that empowers investors to align their capital with Jewish values, is calling upon shareholders of Meta Platforms, Inc. (NASDAQ: META) (“Meta” or the “Company”) to vote FOR Shareholder Proposal 8, which JLens has submitted for shareholder consideration at the Company’s Annual Meeting, to be held on May 27, 2026.

Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced the appointments of Brian Walls as Vice President, Market Access and Darren M. Johnson as Vice President, Commercial Operations.

Supermodel, philanthropist, and women’s advocate Karlie Kloss has joined the Board of Directors of the Lotus Endowment Fund, Inc., the supporting foundation of Lotus House, where she has been actively volunteering for more than five years. In tandem with her appointment to the board of the nation’s largest shelter for women and children, Kloss has pledged $1 million to advance the organization’s mission to support at-risk women and children.

Veryon, a leading provider of aviation software and information services, today announced the launch of four new AI-powered agents within Veryon Tracking. Powered by Veryon AIRE, these new agents include Work Order, Maintenance, Logbook, and Knowledge Base. They are designed to help aviation maintenance teams move faster, reduce manual workload, and make more confident decisions directly within their daily workflows.

Advanced technology company Booz Allen Hamilton (NYSE: BAH) today announced it was awarded an Other Transaction Authority agreement by the U.S. Space Force Space Systems Command as part of Golden Dome for America’s Space-Based Interceptor (SBI) program. The award focuses on the development and delivery of a prototype system for space-based missile defense.

Integrated Data Services (IDS), part of the Arlington Capital Partners portfolio, announces the release of Comprehensive Cost and Requirement (CCaR™) v2026.2.0, which introduces CCaR™ AI Decision Advantage, a significant advancement that embeds decision intelligence, intelligent assistance, and proactive monitoring directly into the platform used by Department of War (DOW) and Federal Civilian acquisition and financial teams.

Westlake Corporation (NYSE: WLK) today announced that its Westlake Epoxy plant in Deer Park, Texas, has received International Sustainability & Carbon Certification (ISCC) PLUS. The certification covers liquid epoxy resins (LER), solid epoxy resins (SER), and liquid epoxy blends that combine LER with reactive modifiers, serving key end-use segments such as industrial coatings, construction, wind energy, composites, automotive and electronics. Starting today, existing and new customers will have access to these ISCC+ mass balance-attributed content of certified renewable feedstock. These solutions support sustainability objectives while maintaining the same quality, performance, and specifications as our standard epoxy resins.

The Caliber family of automotive repair and service brands, including Caliber Collision and Caliber Auto Glass, today announced the appointment of Jason Monaco as Chief Financial Officer (CFO), effective May 4, 2026. In this role, Monaco will oversee Caliber’s financial strategy and operations, supporting the company’s continued growth and strategic investment.

EMCAP Financial (“EMCAP”), an alternative asset manager delivering capital solutions across the residential real estate and private credit ecosystem, today announced the launch of a residential debt platform led by Brendan DeTommaso. The well-capitalized platform is already actively deploying capital and is on pace to fund over $300 million in loans for 2026 and more than $1 billion over the next two years.

Second Front Systems (2F), a public-benefit software company powering software for the free world, announced today it will host its annual Offset Symposium on May 14, 2026, at the historic Mellon Auditorium in Washington, D.C.

Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Fox s.r.l. and XF s.r.l. (“Fox”), expanding the company’s metering and dosing technologies portfolio.

Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced the publication of first-in-human results from its CLOT OUT study demonstrating, for the first time, the ability to accurately characterize clot from inside a fully occluded brain vessel. Just published in the Journal of Neurointerventional Surgery, the study showed that Sensome’s Clotild® Smart Guidewire System can differentiate clot from surrounding tissue and reveal true clot boundaries during mechanical thrombectomy.1 The system also met all primary endpoints of the study.

NCR Voyix (NYSE: VYX), a platform‑powered leader in unified commerce for shopping and dining, today announced a new agreement with Stater Bros. Markets (“Stater Bros.”), a leading supermarket chain in California. The agreement expands the long-standing relationship between the two companies and brings NCR Voyix’s next-generation POS and payments solutions to Stater Bros. on the Voyix Commerce Platform.

Empower announced today that the Municipal Employees’ Retirement System of Michigan (MERS) will be joining the nation’s second-largest1 retirement and wealth management services provider.

Agilent Technologies Inc. (NYSE: A) today announced the appointment of Michael Buckner as chief legal officer, effective today.

Takeda (TSE:4502/NYSE:TAK) today announced that TAK-881-3001, a pivotal Phase 2/3 clinical trial in patients with Primary Immunodeficiency Disease (PID), met its primary endpoint, which demonstrated pharmacokinetic (PK) comparability between the investigational TAK-881 [Immune Globulin Subcutaneous (Human), 20% Solution (SCIG 20%) with Recombinant Human Hyaluronidase] and HYQVIA [Immune Globulin Infusion (Human) 10% with Recombinant Human Hyaluronidase]. Additionally, secondary endpoints showed that TAK-881, a SCIG 20% facilitated with hyaluronidase, demonstrated safety, efficacy and tolerability profiles comparable to HYQVIA, an established SCIG 10% facilitated with hyaluronidase. These findings support the potential of TAK-881 to deliver the required immunoglobulin (IG) dose for PID patients in half the volume of HYQVIA, reducing infusion duration while maintaining flexible, up to once-monthly dosing for patients (every three or four weeks for PID).

Armatus Bio, a late-preclinical stage biotech innovator developing vectorized RNAi medicines in neuromuscular disorders, today announced a new publication in Molecular Therapy Advances summarizing the development of a novel, robust in vitro potency assay platform to accelerate the advancement of gene silencing therapies for serious neuromuscular diseases including facioscapulohumeral muscular dystrophy (FSHD) and Charcot-Marie-Tooth disease type 1A (CMT1A).

Satellite Biosciences, Inc. (Satellite Bio), a biotechnology company developing off-the-shelf liver therapies designed to restore liver function in patients with severe liver diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for SB-101 for the treatment of urea cycle disorders (UCDs).

Iterative Health, a healthcare technology and services company powering the acceleration of clinical research, today announced the presentation of updated scientific research at Digestive Disease Week (DDW) 2026, May 2–5 in Chicago. The abstract builds on findings previously published at the 21st Congress of European Crohn's and Colitis Organisation (ECCO), now reflecting an approximately two-fold increase in network scale across trials and sites. Enrollment rates remain consistently more than 3x industry benchmarks at this expanded scale.

American Express Global Business Travel, which is operated by Global Business Travel Group, Inc. (NYSE: GBTG) ("Amex GBT" or the "Company"), a leading software and services company for travel, expense and meetings & events, today reported first quarter 2026 financial results.

EagleRock Land, LLC (“EagleRock”), a leading land management royalty company that controls surface acreage in the core of the Permian Basin providing access to land, resources, and infrastructure for critical industries, today announced the launch of its initial public offering of 17,300,000 Class A shares representing limited liability company interests (“Class A shares”) at an anticipated initial offering price between $17.00 and $20.00 per Class A share pursuant to a registration statement on Form S-1 (the “Registration Statement”) previously filed with the U.S. Securities and Exchange Commission (the “SEC”). In addition, EagleRock expects to grant the underwriters in the offering a 30-day option to purchase up to an additional 2,595,000 Class A shares at the initial public offering price, less underwriting discounts and commissions. EagleRock has applied to list its Class A shares on the New York Stock Exchange (“NYSE”) and NYSE Texas, Inc. (“NYSE Texas”) under the ticker symbol “EROK.”

The Marzetti Company (Nasdaq: MZTI) reported results today for the company’s fiscal third quarter ended March 31, 2026.

Western Union (NYSE: WU) today announced the launch of USDPT, its U.S. dollar‑denominated payment stablecoin, marking a major milestone in the company’s evolution toward regulated, digital‑first financial infrastructure.

ProPetro Holding Corp. (NYSE: PUMP) (together with its subsidiaries, “ProPetro” or the “Company”) today announced its intention to offer, subject to market and other conditions, $500,000,000 aggregate principal amount of convertible senior notes due 2031 (the “notes”) in a private offering to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). ProPetro also expects to grant the initial purchasers of the notes an option to purchase, for settlement within a period of 13 calendar days from, and including, the date the notes are first issued, up to an additional $75,000,000 aggregate principal amount of notes.

RLJ Lodging Trust (the “Company”) (NYSE: RLJ) today reported results for the three months ended March 31, 2026.

American Express Global Business Travel, which is operated by Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT” or the “Company”), a leading software and services company for travel, expense and meetings & events, today announced that it has entered into a definitive agreement to be acquired by Long Lake Management (“Long Lake”) for $9.50 per share in an all-cash transaction valued at approximately $6.3 billion.

Lincoln Electric Holdings, Inc. (Nasdaq: LECO) today announced that Gabriel Bruno, Executive Vice President and Chief Financial Officer, will speak at the Oppenheimer 21st Annual Industrial Growth Conference being held virtually on Wednesday, May 6, 2026, at 10:30am Eastern Time.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

Vantor, the leader in unified spatial intelligence, has been awarded a $70 million Option Year 1 contract by the National Geospatial-Intelligence Agency (NGA) as part of the Global Enhanced GEOINT Delivery (G-EGD) program.

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today expanded its clonal genes portfolio with the early access launch of Complex Genes.

Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced financial results and business highlights for the second quarter fiscal 2026 ended March 31, 2026.

Sequent Planning has been recognized on USA TODAY’s list of the Best Financial Advisory Firms 2026. This prestigious award is presented by USA TODAY and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list was announced on April 15, 2026, and can be viewed on USATODAY.COM.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal (GI) and rare diseases, presented new findings at Digestive Diseases Week® (DDW) 2026 from a survey assessing healthcare provider (HCP) perspectives on the use of total parenteral nutrition (TPN) in the treatment of short bowel syndrome (SBS). Surveyed HCPs emphasized the importance of reducing patient dependence on TPN to improve quality of life, reduce line infections and lower the risk of thrombosis. The majority (46.4%) identified reducing the number of days per week on TPN as a priority attribute of future therapies. An additional 30.1% prioritized reducing TPN hours per day, while fewer respondents (11.3%) prioritized reducing TPN volume.

Metropolitan Commercial Bank (“MCB” or the “Bank”) today announced that Brian Turano and Tom Kasper have joined the Bank to lead its Government Banking efforts in New Jersey, further expanding MCB’s ability to serve municipalities and public entities across the state.

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that management will conduct its 2026 virtual Annual Meeting of Stockholders followed by a general corporate update on Thursday, June 4, 2026.

Reserv Inc. (“Reserv”), the parent company of Reserv Claims Analysis, LLC - the Property and Casualty (P&C) Insurance industry’s largest AI-native third-party administrator (“TPA”) - and Reserv Technologies, LLC - a claims intelligence provider - today announced a $125 million Series C funding round led by KKR, with participation from existing investors including Bain Capital Ventures and Flourish Ventures, as well as select strategic partners and clients.

The Federal Home Loan Bank of Chicago (FHLBank Chicago) has opened the application period for its 2026 Affordable Housing Program (AHP) General Fund. With $51 million available and up to $2 million per project, the program supports the development and preservation of affordable housing across Illinois and Wisconsin.

Pulse Biosciences, Inc. (Nasdaq: PLSE), developer of novel nPulse™ technology using proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) energy, today announced business updates and financial results for the first quarter ended March 31, 2026.

Helix Energy Solutions Group, Inc. (“Helix”) (NYSE: HLX) announced today the sale of all of the equity interests of its Gulf of America-focused Shallow Water Abandonment business to C-Dive, LLC, a member of the Chouest group of companies, for $107.5 million cash at closing, to be adjusted for working capital and other transaction expenses.

The Middleby Corporation (NASDAQ: MIDD) today announced the filing of the Form 10 registration statement (the “Form 10”) with the U.S. Securities and Exchange Commission (“SEC”) for the planned spin-off of Middleby Food Processing. A copy of the Form 10 is available on the SEC website and can also be viewed on the Investor Page of the Middleby website at middleby.com/investors.

Starting June 4, Best Buy is introducing reward points for its My Best Buy Plus and My Best Buy Total memberships. Plus and Total members will earn 1% back in rewards on every eligible purchase, and 6% back1 in rewards when they use their My Best Buy® Credit Card. Points are in addition to the many benefits members enjoy today, like exclusive pricing and deals, 24/7 tech support, product protection2, free two-day shipping3 and more.

Brera Holdings PLC (Nasdaq: SLMT) (the "Company" or "Solmate Infrastructure"), today issued the following letter from Ron Sade, Chief Executive Officer:

Phillips 66 (NYSE: PSX) will host its 2026 Annual Meeting of Shareholders on Wednesday, May 13 at 8 a.m. CT in a virtual-only format via audio webcast.

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced plans to launch FoundationOne®PGx, a pharmacogenetic (PGx) offering to identify genetic differences that influence how medicines are metabolized and processed by the body. FoundationOne PGx will be offered in the United States through a partnership with Fulgent Genetics, Inc. (NASDAQ: FLGT) and will be available to order through the Foundation Medicine portal.

Forgent Power Solutions, Inc. (NYSE: FPS), a leading designer and manufacturer of electrical distribution equipment used in data centers, the power grid and energy-intensive industrial facilities, will report financial results for its fiscal third quarter ended March 31, 2026, before the market opens on May 14, 2026, and management will host a conference call at 11:00 a.m. ET to discuss the results.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, has enrolled the first participant in a pivotal study for its fully closed-loop (FCL)A automated insulin delivery (AID) system for type 2 diabetes (T2D). FCL for T2D is a breakthrough innovation intended to further improve glycemic outcomes with less burden for users across diverse care settings. That includes eliminating user interactions for bolusing and mealtime announcements for people with T2D as well as settings to start and onboard.

Asbury Automotive Group, Inc. (NYSE: ABG) (the “Company”), one of the largest automotive retail and service companies in the U.S., announced the formal transition of David Hult from CEO to Executive Chairman effective May 4th, 2026.

Qrypt, the pioneering quantum-secure encryption company, today announced that founder and CEO Kevin Chalker will be a featured speaker at Evolve 2026: The Future of Value Creation. The high-level summit, presented by the Digital Evolution Institute, will take place on May 4, hosted at Qrypt’s headquarters in One World Trade Center.

FourKites®, the leader in AI-driven supply chain transformation, today announced Booking Connect for Ocean, the industry's first fully agentic ocean freight booking platform. Part of the FourKites Intelligent Control Tower, Booking Connect automates the contract management, carrier selection, documentation, and exception handling that global shippers have historically outsourced to intermediaries.

Latus Bio, Inc. (Latus), a biotechnology company engineering scalable gene therapies for broader patient populations, today announced the closing of a $97 million Series A financing to support its innovative therapeutics pipeline. The financing includes a $43 million extension led by 8VC, with participation from existing investors DCVC Bio, BioAdvance, Benjamin Franklin Technology Partners, Modi Ventures, Gaingels, and Hatch BioFund. Korea Development Bank and Helen’s Pink Sky Foundation participated as new investors.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases today announced that the Company will have an oral presentation highlighting zelicapavir and two posters with data on EPS-3903, a novel, potent and selective oral STAT6 inhibitor, at the American Thoracic Society (ATS) International Conference 2026 being held May 15-20, 2026 in Orlando, Florida.

Bristol Myers Squibb (NYSE: BMY) today announced the launch of “Won’t Lose,” a new campaign debuting ahead of the FIFA World Cup 2026™. Leveraging a major cultural and global moment, the “Won’t Lose” campaign showcases the relentless mindset that drives Bristol Myers Squibb’s work every day, pushing bold science forward for patients who cannot wait. The “Won’t Lose” mantra embodies the fight, fire and focus that defines BMS, relentlessly advancing breakthrough medicines for patients. The campaign is a pledge to give everything for the patients who depend on BMS and its medicines, and to demonstrate the urgency and purpose behind its mission.